A phase II study of thalidomide in combination with Temodar [temozolomide] in patients with metastatic neuroendocrine tumors
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2007
At a glance
- Drugs Temozolomide (Primary) ; Thalidomide (Primary)
- Indications Neuroendocrine carcinoma
- Focus Therapeutic Use
- 20 Dec 2007 Status changed from in progress to completed.
- 30 Oct 2005 New trial record.